Khoso Baluch

Khoso Baluch is a declared insider at 2 companies; the most frequent names are Longeveron Inc. and Processa Pharmaceuticals, Inc. In total, 11 filings cover trades dated from 9 February 2023 to 26 June 2026.

In open-market terms, that means 3 purchases worth €7,078 on one side and 1 sale worth €2,454 on the other. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 5 share grants and 2 option exercises. In 2026 alone, the filings show 1 purchase and no sales.

2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 30 June 2026 with an option exercise in Processa Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 200 days ago, on 1 April 2026. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.